CompareMarketResearchRequest a sample
Home / Healthcare / Immunoassay

Healthcare · Market report

Immunoassay Market Size, Share and Forecast 2026-2036

The global immunoassay market is worth USD 43.5 bn in 2026 and is forecast to reach USD 81.6 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Reagents and kits is the largest by product segment.

USD 43.5 bnMarket size 2026
USD 81.6 bnForecast 2036
6.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global immunoassay market is worth USD 43.5 bn in 2026 and is forecast to reach USD 81.6 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Reagents and kits is the largest by product segment.

ScopeImmunoassay tests that detect proteins, hormones, antibodies and infectious markers using antibody binding: chemiluminescence, ELISA, fluorescence and rapid assays, with analyzers and reagents.
IndustryHealthcare
Value 2025USD 41.0 bn
Value 2026USD 43.5 bn
Value 2036USD 81.6 bn
CAGR 2026-20366.5%
Volume 20269,446 million tests
Volume 203616,051 million tests
Average price 2026USD 4.60 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Immunoassay market size and forecast, 2026-2036

Exhibit 1The global immunoassay market is forecast to grow from USD 43.5 bn in 2026 to USD 81.6 bn by 2036, a rise of 88%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 6.5%
Immunoassay market value, 2025 to 2036Market value by year. 2025: USD 41.0 bn; 2026: USD 43.5 bn; 2027: USD 46.3 bn; 2028: USD 49.3 bn; 2029: USD 52.5 bn; 2030: USD 55.9 bn; 2031: USD 59.5 bn; 2032: USD 63.4 bn; 2033: USD 67.5 bn; 2034: USD 71.9 bn; 2035: USD 76.6 bn; 2036: USD 81.6 bn. Compound annual growth rate 2026 to 2036: 6.5%.202543.5 bn202659.5 bn203181.6 bn20366.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 43.5 bn
2027USD 46.3 bn
2028USD 49.3 bn
2029USD 52.5 bn
2030USD 55.9 bn
2031USD 59.5 bn
2032USD 63.4 bn
2033USD 67.5 bn
2034USD 71.9 bn
2035USD 76.6 bn
2036USD 81.6 bn

Immunoassay market segmentation

By product

Exhibit 2Reagents and kits is the largest segment by product, with 74.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Immunoassay market share by product, 2026Share of 2026 revenue by product. Reagents and kits: 74.0%; Analyzers: 14.0%; Software and services: 12.0%.Reagents and kits74.0%Analyzers14.0%Software and services12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Reagents and kits74.0%73.6%USD 32.2 bn6.4%
Analyzers14.0%12.7%USD 6.1 bn5.4%
Software and services12.0%13.7%USD 5.2 bn7.9%

By technology

Exhibit 3Chemiluminescence adds the most revenue by technology, growing from USD 22.6 bn in 2026 to USD 47.1 bn by 2036Estimated revenue in USD by technology, 2026 and 2036 forecast
Immunoassay market by technology, 2026 and 2036Revenue by technology in 2026 and 2036. Chemiluminescence: USD 22.6 bn in 2026, USD 47.1 bn in 2036, change +108%; Rapid and lateral flow: USD 7.0 bn in 2026, USD 12.6 bn in 2036, change +81%; ELISA: USD 7.0 bn in 2026, USD 9.9 bn in 2036, change +43%; Fluorescence: USD 3.5 bn in 2026, USD 6.3 bn in 2036, change +81%; Other: USD 3.5 bn in 2026, USD 5.7 bn in 2036, change +65%.20262036 forecastChangeChemiluminescence+108%22.6 bn47.1 bnRapid and lateral flow+81%7.0 bn12.6 bnELISA+43%7.0 bn9.9 bnFluorescence+81%3.5 bn6.3 bnOther+65%3.5 bn5.7 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Chemiluminescence52.0%57.7%USD 22.6 bn7.6%
ELISA16.0%12.2%USD 7.0 bn3.6%
Fluorescence8.0%7.7%USD 3.5 bn6.1%
Rapid and lateral flow16.0%15.4%USD 7.0 bn6.1%
Other8.0%7.0%USD 3.5 bn5.1%

By application

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Infectious diseases26.0%23.7%USD 11.3 bn5.5%
Endocrinology and fertility16.0%16.0%USD 7.0 bn6.5%
Oncology14.0%16.1%USD 6.1 bn8.0%
Cardiology14.0%14.0%USD 6.1 bn6.5%
Autoimmune and allergy10.0%11.0%USD 4.3 bn7.5%
Other20.0%19.1%USD 8.7 bn6.0%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals36.0%34.0%USD 15.6 bn5.9%
Diagnostic laboratories34.0%33.0%USD 14.8 bn6.2%
Pharma and academic16.0%17.0%USD 7.0 bn7.2%
Point of care and home14.0%16.0%USD 6.1 bn7.9%

By automation level

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Fully automated62.0%64.0%USD 26.9 bn6.8%
Semi-automated24.0%22.0%USD 10.4 bn5.6%
Manual and rapid formats14.0%14.0%USD 6.1 bn6.5%

Top 25 countries for immunoassay by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.5% of 2026 revenue and the 25 countries below together hold 94.8%.

Exhibit 4United States is the largest country market at USD 13.5 bn in 2026, and the three largest countries hold 55.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Immunoassay market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 13.5 bn, 31.0%; China: USD 7.4 bn, 17.0%; Germany: USD 3.0 bn, 7.0%; Japan: USD 3.0 bn, 7.0%; France: USD 1.7 bn, 4.0%; United Kingdom: USD 1.5 bn, 3.5%; Italy: USD 1.5 bn, 3.5%; Brazil: USD 1.3 bn, 3.0%; India: USD 1.3 bn, 3.0%; Spain: USD 1.1 bn, 2.5%.United States13.5 bn 31.0%China7.4 bn 17.0%Germany3.0 bn 7.0%Japan3.0 bn 7.0%France1.7 bn 4.0%United Kingdom1.5 bn 3.5%Italy1.5 bn 3.5%Brazil1.3 bn 3.0%India1.3 bn 3.0%Spain1.1 bn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 13.5 bn31.0%USD 23.1 bn5.5%
2ChinaUSD 7.4 bn17.0%USD 17.5 bn9.0%
3GermanyUSD 3.0 bn7.0%USD 5.0 bn5.0%
4JapanUSD 3.0 bn7.0%USD 4.7 bn4.5%
5FranceUSD 1.7 bn4.0%USD 2.9 bn5.1%
6United KingdomUSD 1.5 bn3.5%USD 2.6 bn5.5%
7ItalyUSD 1.5 bn3.5%USD 2.4 bn4.9%
8BrazilUSD 1.3 bn3.0%USD 2.7 bn7.5%
9IndiaUSD 1.3 bn3.0%USD 3.7 bn10.9%
10SpainUSD 1.1 bn2.5%USD 1.9 bn5.6%
11CanadaUSD 600 mn1.4%USD 1.1 bn5.8%
12South KoreaUSD 600 mn1.4%USD 1.1 bn5.8%
13MexicoUSD 526 mn1.2%USD 1.2 bn8.1%
14AustraliaUSD 526 mn1.2%USD 922 mn5.8%
15RussiaUSD 452 mn1.0%USD 783 mn5.7%
16TurkeyUSD 452 mn1.0%USD 987 mn8.1%
17NetherlandsUSD 374 mn0.9%USD 653 mn5.7%
18SwitzerlandUSD 374 mn0.9%USD 653 mn5.7%
19PolandUSD 300 mn0.7%USD 522 mn5.7%
20TaiwanUSD 300 mn0.7%USD 522 mn5.7%
21IndonesiaUSD 300 mn0.7%USD 783 mn10.1%
22Saudi ArabiaUSD 300 mn0.7%USD 653 mn8.1%
23ThailandUSD 226 mn0.5%USD 489 mn8.0%
24IranUSD 226 mn0.5%USD 392 mn5.7%
25BelgiumUSD 226 mn0.5%USD 392 mn5.7%
Rest of worldUSD 2.3 bn5.2%USD 4.1 bn6.1%
Exhibit 5China and United States account for 52% of the USD 38.1 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Immunoassay market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 43.5 bn. China: +USD 10.2 bn; United States: +USD 9.6 bn; India: +USD 2.4 bn; Germany: +USD 1.9 bn; Japan: +USD 1.7 bn; 20 other countries: +USD 10.5 bn; Rest of world: +USD 1.8 bn. Market value 2036: USD 81.6 bn.Market value 202643.5 bnChina+10.2 bnUnited States+9.6 bnIndia+2.4 bnGermany+1.9 bnJapan+1.7 bn20 other countries+10.5 bnRest of world+1.8 bnMarket value 203681.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Roche
  • Abbott
  • Siemens Healthineers
  • Beckman Coulter
  • bioMerieux
  • QuidelOrtho
  • Thermo Fisher Scientific

Group 2: Regional and specialist players

  • Bio-Rad Laboratories
  • DiaSorin
  • Sysmex
  • Snibe Diagnostics
  • Tosoh
  • Fujirebio
  • Revvity
  • Werfen
  • Randox Laboratories

Group 3: Emerging and niche players

  • Mindray
  • Autobio Diagnostics
  • Maccura Biotechnology
  • Getein Biotech
  • Boditech Med
  • Wondfo Biotech
  • Hotgen Biotech

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the immunoassay market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.

The market is divided by product, by technology, by application, by end user, by automation level. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the immunoassay market?

The global immunoassay market is estimated at USD 41.0 bn in 2025 and USD 43.5 bn in 2026.

How fast will the immunoassay market grow?

It is forecast to reach USD 81.6 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 38.1 bn.

Which country is the largest market for immunoassay?

United States is the largest market by revenue at USD 13.5 bn in 2026, 31.0% of the global total. The three largest countries together hold 55.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 10.9% a year from 2026 to 2036.

Which immunoassay segment is largest?

In the by product split, Reagents and kits is the largest segment with 74.0% of 2026 revenue.

Who are the leading immunoassay companies?

Global leaders include Roche, Abbott, Siemens Healthineers, Beckman Coulter.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Immunoadsorption Columns Immunohistochemistry →

All Healthcare markets →

Request a sample